| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 93.85▲ | 94.13▲ | 94.67▼ | 90.45▲ | 89.71▲ |
| MA10 | 93.78▲ | 95.05▼ | 94.40▲ | 89.89▲ | 95.28▼ |
| MA20 | 93.75▲ | 94.55▲ | 92.33▲ | 90.29▲ | 86.86▲ |
| MA50 | 94.75▼ | 91.55▲ | 90.40▲ | 96.14▼ | 70.56▲ |
| MA100 | 94.71▼ | 90.37▲ | 90.95▲ | 85.53▲ | 55.39▲ |
| MA200 | 92.83▲ | 90.92▲ | 92.65▲ | 75.01▲ | 40.37▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.141▲ | -0.329▼ | 0.123▲ | 0.493▲ | -1.138▼ |
| RSI | 60.589▲ | 56.599▲ | 60.849▲ | 54.731▲ | 60.369▲ |
| STOCH | 45.678 | 25.931 | 57.000 | 47.769 | 32.256 |
| WILL %R | -12.715▲ | -50.377 | -27.162 | -21.602▲ | -41.314 |
| CCI | 320.008▲ | -50.774 | 15.039 | 150.488▲ | 2.925 |
| ▲ PSAR&MOM | $MIRM PSAR Switch Up + Momentum | Set Alert |
|
Wednesday, April 01, 2026 01:53 PM
Bile Acid Medicines Sales -- $41 million attributed to CHOLBAM and CTEXLI medicines supported by expanded CTX patient finding after CTEXLI's FDA approval. Revenue Potential -- Management projects peak ...
|
|
Wednesday, April 01, 2026 01:47 PM
CTEXLI approved by FDA for CTX; LIVMARLI approved in Japan for PFIC and Alagille syndrome with partner Takeda; and a single tablet LIVMARLI formulation approved by the FDA. Access dynamics -- LIVMARLI ...
|
|
Friday, March 20, 2026 10:20 AM
Mirum Pharmaceuticals Inc. (NASDAQ:MIRM) is one of the most promising stocks under $100 to buy. On March 16, Mirum Pharmaceuticals announced the completion of enrollment for its Phase 3 EXPAND study, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/04/26 | 93.85 | 97.30 | 93.36 | 94.63 | 656,495 |
| 31/03/26 | 89.01 | 94.915 | 86.97 | 92.38 | 1,759,034 |
| 30/03/26 | 88.88 | 89.68 | 87.38 | 87.90 | 1,613,603 |
| 27/03/26 | 89.42 | 90.15 | 87.57 | 88.44 | 934,367 |
| 26/03/26 | 89.69 | 90.87 | 88.409 | 88.88 | 672,844 |
| 25/03/26 | 88.89 | 91.73 | 88.35 | 90.17 | 487,790 |
| 24/03/26 | 88.27 | 88.39 | 84.94 | 87.88 | 885,313 |
| 23/03/26 | 88.98 | 91.54 | 87.94 | 89.43 | 1,145,637 |
| 20/03/26 | 90.73 | 91.70 | 86.95 | 88.51 | 1,771,175 |
| 19/03/26 | 90.75 | 94.16 | 90.00 | 90.72 | 961,160 |
|
|
||||
|
|
||||
|
|